Clinical Trial

A Study of MHB009C in Patients With Advanced Solid Tumors

Name: A Study of MHB009C in Patients With Advanced Solid Tumors — clinical trial record (NCT07326488)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is a first-in-human, open-label, multicenter Phase I/II study of MHB009C in patients with advanced solid tumors. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of MHB009C monotherapy.

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-14

Trial Details

NCT Number	NCT07326488
Lead Sponsor	Minghui Pharmaceutical (Hangzhou) Ltd
Conditions	Advanced Malignant Solid Tumor
Enrollment	200 participants
Start Date	2026-03-17
Primary Completion	2028-02 (estimated)
Study Completion	2029-03 (estimated)
Updated on ClinicalTrials.gov	2026-04-13